Endogenous Nodal signaling regulates germ cell potency during mammalian testis development

Development (Cambridge)

Volumn 139, Issue 22, 2012, Pages 4123-4132

  Spiller, Cassy M ^a   Feng, Chun Wei ^a   Jackson, Andrew ^a   Gillis, Ad J M ^b   Rolland, Antoine D ^a   Looijenga, Leendert H J ^b   Koopman, Peter ^a   Bowles, Josephine ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

Author keywords

Germ cell; Mouse; Nodal; Pluripotency

Indexed keywords

COREPRESSOR PROTEIN; FIBROBLAST GROWTH FACTOR 9; NODAL SIGNALING PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; EMBRYONIC STEM CELL; GERM CELL; GERM CELL TUMOR; IN VITRO STUDY; MALE; MAMMALIAN GENETICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; TESTIS CANCER; TESTIS DEVELOPMENT;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 9; GERM CELLS; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MICE; NEOPLASM PROTEINS; NEOPLASMS, GERM CELL AND EMBRYONAL; NODAL PROTEIN; PLURIPOTENT STEM CELLS; SIGNAL TRANSDUCTION; SPERMATOGENESIS; SPERMATOGONIA; TESTICULAR NEOPLASMS; TESTIS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84867850177     PISSN: 09501991     EISSN: 14779129     Source Type: Journal    
DOI: 10.1242/dev.083006     Document Type: Article

References (61)

1. Alberio, R., Croxall, N. and Allegrucci, C. (2010). Pig epiblast stem cells depend on activin/nodal signaling for pluripotency and self-renewal. Stem Cells Dev. 19, 1627-1636.
2. Baldassarre, G., Romano, A., Armenante, F., Rambaldi, M., Paoletti, I., Sandomenico, C., Pepe, S., Staibano, S., Salvatore, G., De Rosa, G. et al. (1997). Expression of teratocarcinoma-derived growth factor-1 (TDGF-1) in testis germ cell tumors and its effects on growth and differentiation of embryonal carcinoma cell line NTERA2/D1. Oncogene 15, 927-936.
3. Barrios, F., Filipponi, D., Pellegrini, M., Paronetto, M. P., Di Siena, S., Geremia, R., Rossi, P., De Felici, M., Jannini, E. A. and Dolci, S. (2010). Opposing effects of retinoic acid and FGF9 on Nanos2 expression and meiotic entry of mouse germ cells. J. Cell Sci. 123, 871-880.
4. Bianco, C., Strizzi, L., Ebert, A., Chang, C., Rehman, A., Normanno, N., Guedez, L., Salloum, R., Ginsburg, E., Sun, Y. et al. (2005). Role of human cripto-1 in tumor angiogenesis. J. Natl. Cancer Inst. 97, 132-141.
5. Bianco, C., Rangel, M. C., Castro, N. P., Nagaoka, T., Rollman, K., Gonzales, M. and Salomon, D. S. (2010). Role of Cripto-1 in stem cell maintenance and malignant progression. Am. J. Pathol. 177, 532-540.
6. Bowles, J., Knight, D., Smith, C., Wilhelm, D., Richman, J., Mamiya, S., Yashiro, K., Chawengsaksophak, K., Wilson, M. J., Rossant, J. et al. (2006). Retinoid signaling determines germ cell fate in mice. Science 312, 596-600.
7. Bowles, J., Feng, C. W., Spiller, C., Davidson, T. L., Jackson, A. and Koopman, P. (2010). FGF9 suppresses meiosis and promotes male germ cell fate in mice. Dev. Cell 19, 440-449.
8. Brennan, J., Lu, C. C., Norris, D. P., Rodriguez, T. A., Beddington, R. S. and Robertson, E. J. (2001). Nodal signalling in the epiblast patterns the early mouse embryo. Nature 411, 965-969.
9. Brons, I. G., Smithers, L. E., Trotter, M. W., Rugg-Gunn, P., Sun, B., ChuvadeSousa Lopes, S. M., Howlett, S. K., Clarkson, A., Ahrlund-Richter, L., Pedersen, R. A. et al. (2007). Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature 448, 191-195.
10. Buehr, M., McLaren, A., Bartley, A. and Darling, S. (1993). Proliferation and migration of primordial germ cells in We/We mouse embryos. Dev. Dyn. 198, 182-189.
11. Camus, A., Perea-Gomez, A., Moreau, A. and Collignon, J. (2006). Absence of Nodal signaling promotes precocious neural differentiation in the mouse embryo. Dev. Biol. 295, 743-755.
12. Ciccodicola, A., Dono, R., Obici, S., Simeone, A., Zollo, M. and Persico, M. G. (1989). Molecular characterization of a gene of the 'EGF family' expressed in undifferentiated human NTERA2 teratocarcinoma cells. EMBO J. 8, 1987-1991.
13. Colvin, J. S., Green, R. P., Schmahl, J., Capel, B. and Ornitz, D. M. (2001). Male-to-female sex reversal in mice lacking fibroblast growth factor 9. Cell 104, 875-889.
14. de Jong, J., Stoop, H., Gillis, A. J., van Gurp, R. J., van de Geijn, G. J., Boer, M., Hersmus, R., Saunders, P. T., Anderson, R. A., Oosterhuis, J. W. et al. (2008). Differential expression of SOX17 and SOX2 in germ cells and stem cells has biological and clinical implications. J. Pathol. 215, 21-30.
15. DiNapoli, L., Batchvarov, J. and Capel, B. (2006). FGF9 promotes survival of germ cells in the fetal testis. Development 133, 1519-1527.
16. Durcova-Hills, G. and Surani, A. (2008). Reprogramming primordial germ cells (PGC) to embryonic germ (EG) cells, Curr. Protoc. Stem Cell Biol. 2008, Chapter 1: Unit 1A.3.
17. Durcova-Hills, G., Adams, I. R., Barton, S. C., Surani, M. A. and McLaren, A. (2006). The role of exogenous fibroblast growth factor-2 on the reprogramming of primordial germ cells into pluripotent stem cells. Stem Cells 24, 1441-1449.
18. Gillis, A. J., Stoop, H., Biermann, K., van Gurp, R. J., Swartzman, E., Cribbes, S., Ferlinz, A., Shannon, M., Oosterhuis, J. W. and Looijenga, L. H. (2011). Expression and interdependencies of pluripotency factors LIN28, OCT3/4, NANOG and SOX2 in human testicular germ cells and tumours of the testis. Int. J. Androl. 34, e160-e174.
19. Gray, P. C., Harrison, C. A. and Vale, W. (2003). Cripto forms a complex with activin and type II activin receptors and can block activin signaling. Proc. Natl. Acad. Sci. USA 100, 5193-5198.
20. Gray, P. C., Shani, G., Aung, K., Kelber, J. and Vale, W. (2006). Cripto binds transforming growth factor beta (TGF-beta) and inhibits TGF-beta signaling. Mol. Cell. Biol. 26, 9268-9278.
21. Guzman-Ayala, M., Ben-Haim, N., Beck, S. and Constam, D. B. (2004). Nodal protein processing and fibroblast growth factor 4 synergize to maintain a trophoblast stem cell microenvironment. Proc. Natl. Acad. Sci. USA 101, 15656-15660.
22. Hammond, S. S. and Matin, A. (2009). Tools for the genetic analysis of germ cells. Genesis 47, 617-627.
23. Holt, J. E., Jackson, A., Roman, S. D., Aitken, R. J., Koopman, P. and McLaughlin, E. A. (2006). CXCR4/SDF1 interaction inhibits the primordial to primary follicle transition in the neonatal mouse ovary. Dev. Biol. 293, 449-460.
24. Honda, A., Hirose, M. and Ogura, A. (2009). Basic FGF and Activin/Nodal but not LIF signaling sustain undifferentiated status of rabbit embryonic stem cells. Exp. Cell Res. 315, 2033-2042.
25. James, D., Levine, A. J., Besser, D. and Hemmati-Brivanlou, A. (2005). TGFbeta/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells. Development 132, 1273-1282.
26. Kehler, J., Tolkunova, E., Koschorz, B., Pesce, M., Gentile, L., Boiani, M., Lomelí, H., Nagy, A., McLaughlin, K. J., Schöler, H. R. et al. (2004). Oct4 is required for primordial germ cell survival. EMBO Rep. 5, 1078-1083.
27. Kelly, R. K., Olson, D. L., Sun, Y., Wen, D., Wortham, K. A., Antognetti, G., Cheung, A. E., Orozco, O. E., Yang, L., Bailly, V. et al. (2011). An antibodycytotoxic conjugate, BIIB015, is a new targeted therapy for Cripto positive tumours. Eur. J. Cancer 47, 1736-1746.
28. Koubova, J., Menke, D. B., Zhou, Q., Capel, B., Griswold, M. D. and Page, D. C. (2006). Retinoic acid regulates sex-specific timing of meiotic initiation in mice. Proc. Natl. Acad. Sci. USA 103, 2474-2479.
29. Lomelí, H., Ramos-Mejía, V., Gertsenstein, M., Lobe, C. G. and Nagy, A. (2000). Targeted insertion of Cre recombinase into the TNAP gene: excision in primordial germ cells. Genesis 26, 116-117.
30. Looijenga, L. H. (2009). Human testicular (non)seminomatous germ cell tumours: the clinical implications of recent pathobiological insights. J. Pathol. 218, 146-162.
31. Looijenga, L. H. and Oosterhuis, J. W. (1999). Pathogenesis of testicular germ cell tumours. Rev. Reprod. 4, 90-100.
32. Looijenga, L. H., Stoop, H., de Leeuw, H. P., de Gouveia Brazao, C. A., Gillis, A. J., van Roozendaal, K. E., van Zoelen, E. J., Weber, R. F., Wolffenbuttel, K. P., van Dekken, H. et al. (2003). POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res. 63, 2244-2250.
33. Looijenga, L. H., Gillis, A. J., Stoop, H., Biermann, K. and Oosterhuis, J. W. (2011). Dissecting the molecular pathways of (testicular) germ cell tumour pathogenesis; from initiation to treatment-resistance. Int. J. Androl. 34, e234-e251.
34. Lowe, L. A., Yamada, S. and Kuehn, M. R. (2001). Genetic dissection of nodal function in patterning the mouse embryo. Development 128, 1831-1843.
35. Matsui, Y. and Tokitake, Y. (2009). Primordial germ cells contain subpopulations that have greater ability to develop into pluripotential stem cells. Dev. Growth Differ. 51, 657-667.
36. Matsui, Y., Zsebo, K. and Hogan, B. L. (1992). Derivation of pluripotential embryonic stem cells from murine primordial germ cells in culture. Cell 70, 841-847.
37. McLaren, A. (1983). Primordial germ cells in mice. Bibl. Anat. 24, 59-66.
38. Mendis, S. H., Meachem, S. J., Sarraj, M. A. and Loveland, K. L. (2011). Activin A balances sertoli and germ cell proliferation in the fetal mouse testis. Biol. Reprod. 84, 379-391.
39. Mesnard, D., Guzman-Ayala, M. and Constam, D. B. (2006). Nodal specifies embryonic visceral endoderm and sustains pluripotent cells in the epiblast before overt axial patterning. Development 133, 2497-2505.
40. Mithraprabhu, S., Mendis, S., Meachem, S. J., Tubino, L., Matzuk, M. M., Brown, C. W. and Loveland, K. L. (2010). Activin bioactivity affects germ cell differentiation in the postnatal mouse testis in vivo. Biol. Reprod. 82, 980-90.
41. Monk, M. and McLaren, A. (1981). X-chromosome activity in foetal germ cells of the mouse. J. Embryol. Exp. Morphol. 63, 75-84.
42. Moreno, S. G., Attali, M., Allemand, I., Messiaen, S., Fouchet, P., Coffigny, H., Romeo, P. H. and Habert, R. (2010). TGFbeta signaling in male germ cells regulates gonocyte quiescence and fertility in mice. Dev. Biol. 342, 74-84.
43. Mosselman, S., Looijenga, L. H., Gillis, A. J., van Rooijen, M. A., Kraft, H. J., van Zoelen, E. J. and Oosterhuis, J. W. (1996). Aberrant platelet-derived growth factor alpha-receptor transcript as a diagnostic marker for early human germ cell tumors of the adult testis. Proc. Natl. Acad. Sci. USA 93, 2884-2888.
44. Oosterhuis, J. W. and Looijenga, L. H. (2005). Testicular germ-cell tumours in a broader perspective. Nat. Rev. Cancer 5, 210-222.
45. Postovit, L. M., Margaryan, N. V., Seftor, E. A., Kirschmann, D. A., Lipavsky, A., Wheaton, W. W., Abbott, D. E., Seftor, R. E. and Hendrix, M. J. (2008). Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells. Proc. Natl. Acad. Sci. USA 105, 4329-4334.
46. Resnick, J. L., Bixler, L. S., Cheng, L. and Donovan, P. J. (1992). Long-term proliferation of mouse primordial germ cells in culture. Nature 359, 550-551.
47. Schier, A. F. (2003). Nodal signaling in vertebrate development. Annu. Rev. Cell Dev. Biol. 19, 589-621.
48. Schier, A. F. (2009). Nodal morphogens. Cold Spring Harb. Perspect. Biol. 1, a003459.
49. Shen, M. M. (2007). Nodal signaling: developmental roles and regulation. Development 134, 1023-1034.
50. Skakkebæk, N. E., Berthelsen, J. G., Giwercman, A. and Müller, J. (1987). Carcinoma-in-situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma. Int. J. Androl. 10, 19-28.
51. Souquet, B., Tourpin, S., Messiaen, S., Moison, D., Habert, R. and Livera, G. (2012). Nodal signaling regulates the entry into meiosis in fetal germ cells. Endocrinology 153, 2466-2473.
52. Speed, R. M. (1982). Meiosis in the foetal mouse ovary. I. An analysis at the light microscope level using surface-spreading. Chromosoma 85, 427-437.
53. Strizzi, L., Bianco, C., Normanno, N. and Salomon, D. (2005). Cripto-1: a multifunctional modulator during embryogenesis and oncogenesis. Oncogene 24, 5731-5741.
54. Suzuki, A. and Saga, Y. (2008). Nanos2 suppresses meiosis and promotes male germ cell differentiation. Genes Dev. 22, 430-435.
55. Szabó, P. E., Hübner, K., Schöler, H. and Mann, J. R. (2002). Allele-specific expression of imprinted genes in mouse migratory primordial germ cells. Mech. Dev. 115, 157-160.
56. Tesar, P. J., Chenoweth, J. G., Brook, F. A., Davies, T. J., Evans, E. P., Mack, D. L., Gardner, R. L. and McKay, R. D. (2007). New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature 448, 196-199.
57. Tsuda, M., Sasaoka, Y., Kiso, M., Abe, K., Haraguchi, S., Kobayashi, S. and Saga, Y. (2003). Conserved role of nanos proteins in germ cell development. Science 301, 1239-1241.
58. Vallier, L., Alexander, M. and Pedersen, R. A. (2005). Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells. J. Cell Sci. 118, 4495-4509.
59. van den Bergen, J. A., Miles, D. C., Sinclair, A. H. and Western, P. S. (2009). Normalizing gene expression levels in mouse fetal germ cells. Biol. Reprod. 81, 362-370.
60. Watanabe, K., Meyer, M. J., Strizzi, L., Lee, J. M., Gonzales, M., Bianco, C., Nagaoka, T., Farid, S. S., Margaryan, N., Hendrix, M. J. et al. (2010). Cripto- 1 is a cell surface marker for a tumorigenic, undifferentiated subpopulation in human embryonal carcinoma cells. Stem Cells 28, 1303-1314.
61. Wechselberger, C., Strizzi, L., Kenney, N., Hirota, M., Sun, Y., Ebert, A., Orozco, O., Bianco, C., Khan, N. I., Wallace-Jones, B. et al. (2005). Human Cripto-1 overexpression in the mouse mammary gland results in the development of hyperplasia and adenocarcinoma. Oncogene 24, 4094-4105.